Table 1.
Patient demographics, and perioperative results stratified by surgery type for all diagnosed ccRCC.
Table 2.
Patients who died or suffer from recurrence of disease during follow-up stratified by surgery type for all diagnosed ccRCC.
Fig 1.
OS for 123 patients cT2 after radical nephrectomy (RN, n = 105) or elective NSS (n = 18) for ccRCC ≥7cm. Comparison of survival analysis performed using log-rank (Mantel-Cox) test; Chi square 5.94, P = 0.014. Median OS was 149 months (range 3–367), for NSS and was not reached for NSS.
Fig 2.
Cancer-specific survival (CCS).
CSS for 123 patients cT2 after radical nephrectomy or elective NSS for ccRCC ?7cm. Comparison of survival analysis performed using log-rank (Mantel-Cox) test; Chi square: 3.35, P = 0.04. Median survival for RN was 164 months (range 3–367 months), for NSS not reached.
Table 3.
Overview of the current literature, comparing studies with patients presenting pT2 and cT2 RCC and treated by nephron sparing surgery (NSS) or radical nephrectomy (RN).
Synopsis current literature.
Table 4.
Overview of the recurrence and survival of the current literature, comparing studies with patients presenting pT2 and cT2 RCC and treated by nephron sparing surgery (NSS) or radical nephrectomy (RN).